OTCMKTS:BAYRY - Bayer Aktiengesellschaft Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $60.00
  • Forecasted Upside: 337.64 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 7 Hold Ratings
  • 9 Buy Ratings
  • 0 Strong Buy Ratings
$13.71
▼ -0.03 (-0.22%)

This chart shows the closing price for BAYRY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bayer Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BAYRY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BAYRY

Analyst Price Target is $60.00
▲ +337.64% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Bayer Aktiengesellschaft in the last 3 months. The average price target is $60.00, with a high forecast of $60.00 and a low forecast of $60.00. The average price target represents a 337.64% upside from the last price of $13.71.

This chart shows the closing price for BAYRY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 16 polled investment analysts is to buy stock in Bayer Aktiengesellschaft. This rating has held steady since January 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/4/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/3/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/1/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 0 sell ratings
12/30/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 8 hold ratings
  • 0 sell ratings
3/30/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 0 sell ratings
6/28/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 8 hold ratings
  • 0 sell ratings
8/27/2021
  • 0 strong buy ratings
  • 9 buy ratings
  • 7 hold ratings
  • 0 sell ratings
9/26/2021

Latest Recommendations

  • 0 strong buy ratings
  • 9 buy ratings
  • 7 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/9/2021Berenberg BankLower Price TargetBuy€74.00 ➝ €60.00
8/6/2021Credit Suisse GroupReiterated RatingNeutral
8/4/2021AlphaValueDowngradeBuy
6/25/2021Kepler Capital MarketsReiterated RatingBuy
5/26/2021DZ BankReiterated RatingBuy
5/19/2021Morgan StanleyReiterated RatingOverweight
5/18/2021JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
5/14/2021DZ BankReiterated RatingBuy
5/13/2021Credit Suisse GroupReiterated RatingNeutral
5/13/2021Bryan, Garnier & CoUpgradeSell ➝ Neutral
3/30/2021DZ BankReiterated RatingBuy
3/19/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
3/11/2021Societe GeneraleReiterated RatingHold
3/4/2021Berenberg BankReiterated RatingBuy
3/1/2021Morgan StanleyReiterated RatingOverweight
3/1/2021DZ BankReiterated RatingBuy
2/26/2021Credit Suisse GroupReiterated RatingNeutral
2/10/2021BarclaysReiterated RatingEqual Weight
2/4/2021DZ BankReiterated RatingBuy
1/27/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
1/20/2021Credit Suisse GroupReiterated RatingNeutral
1/8/2021Morgan StanleyReiterated RatingOverweight
1/6/2021Nord/LBReiterated RatingBuy
11/6/2020Morgan StanleyReiterated RatingOverweight
11/5/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
11/5/2020JPMorgan Chase & Co.Reiterated RatingNeutral
11/4/2020Credit Suisse GroupReiterated RatingNeutral
10/21/2020Morgan StanleyReiterated RatingOverweight
10/13/2020BarclaysDowngradeOverweight ➝ Equal Weight
10/5/2020UBS GroupReiterated RatingBuy
10/2/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/2/2020AlphaValueDowngradeBuy
10/1/2020Bryan, Garnier & CoDowngradeNeutral ➝ Sell
10/1/2020CitigroupDowngradeBuy ➝ Neutral
10/1/2020HSBCDowngradeBuy ➝ Hold
10/1/2020CommerzbankDowngradeBuy ➝ Hold
9/14/2020Morgan StanleyReiterated RatingOverweight
9/9/2020BMO Capital MarketsInitiated CoverageMarket Perform
9/3/2020Credit Suisse GroupInitiated CoverageNeutral
8/11/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
8/10/2020Morgan StanleyReiterated RatingOverweight
6/26/2020JPMorgan Chase & Co.Reiterated RatingNeutral
6/26/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
6/25/2020Morgan StanleyReiterated RatingOverweight
6/25/2020HSBCUpgradeHold ➝ Buy
6/16/2020CommerzbankUpgradeHold ➝ Buy
4/22/2020Morgan StanleyReiterated RatingOverweight
3/4/2020Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy
12/17/2019Berenberg BankUpgradeHold ➝ Buy
8/16/2019Bank of AmericaUpgradeNeutral ➝ Buy
4/1/2019Berenberg BankInitiated CoverageBuy ➝ Hold
3/31/2019Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
3/28/2019Bryan, Garnier & CoDowngradeNeutral ➝ Sell
3/25/2019Bank of AmericaReiterated RatingBuy ➝ Neutral
1/2/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
9/20/2018CitigroupUpgradeNeutral ➝ Buy
8/21/2018Berenberg BankUpgradeHold ➝ Buy
8/15/2018Jefferies Financial GroupDowngradeBuy ➝ Hold
8/13/2018JPMorgan Chase & Co.Reiterated RatingBuy
5/17/2018DZ BankReiterated RatingBuy
9/25/2017BNP ParibasUpgradeNeutral ➝ Outperform
7/3/2017Berenberg BankDowngradeBuy ➝ Hold
2/24/2017Sanford C. BernsteinReiterated RatingOutperform
1/4/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
12/19/2016Jefferies Financial GroupUpgradeHold ➝ Buy
12/7/2016UBS GroupUpgradeNeutral ➝ Buy
(Data available from 9/27/2016 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 3 very negative mentions
3/1/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/31/2021
  • 0 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/30/2021
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/29/2021
  • 6 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/29/2021
  • 6 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 6 very negative mentions
8/28/2021
  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 3 very negative mentions
9/27/2021

Current Sentiment

  • 3 very positive mentions
  • 10 positive mentions
  • 2 negative mentions
  • 3 very negative mentions

Recent Stories by Sentiment

Bayer Aktiengesellschaft logo
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by
Read More

Today's Range

Now: $13.71
Low: $13.62
High: $13.71

50 Day Range

MA: $14.11
Low: $13.25
High: $15.13

52 Week Range

Now: $13.71
Low: $11.65
High: $17.34

Volume

345,800 shs

Average Volume

450,789 shs

Market Capitalization

$53.88 billion

P/E Ratio

N/A

Dividend Yield

2.99%

Beta

1.27

Frequently Asked Questions

What sell-side analysts currently cover shares of Bayer Aktiengesellschaft?

The following Wall Street analysts have issued reports on Bayer Aktiengesellschaft in the last twelve months: AlphaValue, Barclays PLC, Berenberg Bank, Bryan, Garnier & Co, Citigroup Inc., Commerzbank AG, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, DZ Bank AG, HSBC Holdings plc, JPMorgan Chase & Co., Kepler Capital Markets, Morgan Stanley, Nord/LB, Societe Generale, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for BAYRY.

What is the current price target for Bayer Aktiengesellschaft?

1 Wall Street analysts have set twelve-month price targets for Bayer Aktiengesellschaft in the last year. Their average twelve-month price target is $60.00, suggesting a possible upside of 337.6%. Berenberg Bank has the highest price target set, predicting BAYRY will reach $60.00 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of $60.00 for Bayer Aktiengesellschaft in the next year.
View the latest price targets for BAYRY.

What is the current consensus analyst rating for Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft currently has 7 hold ratings and 9 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BAYRY will outperform the market and that investors should add to their positions of Bayer Aktiengesellschaft.
View the latest ratings for BAYRY.

What other companies compete with Bayer Aktiengesellschaft?

How do I contact Bayer Aktiengesellschaft's investor relations team?

Bayer Aktiengesellschaft's physical mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company's listed phone number is 49214301 and its investor relations email address is [email protected] The official website for Bayer Aktiengesellschaft is www.bayer.com.